Metabolomics Identifies Pre-clinical Biomarker of Acute Renal Injury

We are delighted to present the sixth in a series of case studies showing how metabolomics can help you unlock your biomarker discovery program. In this example, our client successfully developed a routine, sensitive test to detect off-target effects of drugs on the kidney in pre-clinical studies. They used this to inform the early development of novel therapy for high cholesterol levels.